Atara Q2 Revenue Beats, Cash Runway Extended to Mid-2027
ATRA has more than doubled off its 52-week low of $3.92.
Summary
Atara reported Q2 revenue of $630,000, beating the $366,670 consensus, though down sharply year-over-year due to deferred revenue recognition. Net loss was $4.83 million, or $0.32 per share. Operating expenses fell 87% year-over-year after cost cuts, and the company now expects cash to fund operations into mid-2027. A regulatory update on the tabelecleucel BLA resubmission is expected later this quarter. This follows the Q1 10-Q that highlighted reduced cash burn and a going concern warning; the extended runway and upcoming BLA update are the key positives.
At the time of this announcement, ATRA was trading at $9.48 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $83.1M. The 52-week trading range was $3.92 to $19.15. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.